|
Market Closed -
Nasdaq
21:00:00 10/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 170.87 USD | +0.92% |
|
+2.03% | +39.21% |
| 11:01am | CAR-T trial deaths do not deter lupus patients hoping for a cure | RE |
| 11-10 | Gilead Sciences, Inc. Presents at 8th Annual Wolfe Research Healthcare Conference, Nov-10-2026 11:20 AM |
| Market Cap | 212B 190B 175B 159B 301B 19,871B 309B 2,097B 836B 10,646B 795B 779B 33,655B | P/E 2026 * |
-40.1x | P/E 2027 * | 20.6x |
|---|---|---|---|---|---|
| Enterprise Value | 233B 209B 193B 175B 331B 21,844B 340B 2,306B 919B 11,703B 874B 856B 36,998B | EV / Sales 2026 * |
7.43x | EV / Sales 2027 * | 6.66x |
| Free-Float |
99.89% | Yield 2026 * |
1.93% | Yield 2027 * | 1.98% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GILD | Delayed | |
CBOE
| GILD | Real-time | |
|
Mexican S.E.
| GILD * | End-of-day quote | |
|
Xetra
| GIS | Delayed | |
|
Tradegate
| GIS | Real-time | |
|
Wiener Boerse
| GILD | End-of-day quote | |
|
Boerse Muenchen
| GIS | Real-time | |
|
CBOE
| Real-time | ||
|
Borsa Italiana
| 1GILD | End-of-day quote | |
|
Deutsche Boerse AG
| GIS | Delayed | |
|
Swiss Exchange
| GILD | Delayed | |
|
London S.E.
| 0QYQ | Delayed | |
|
Börse Stuttgart
| GIS | Delayed | |
|
Santiago S.E.
| GILD | End-of-day quote | |
|
Lima
| GILDUS | End-of-day quote | |
|
Santiago S.E.
| GILDCL | End-of-day quote | |
|
Swiss Exchange
| GILD | Delayed | |
|
CBOE
| 0QYQ | Real-time |
Last Transcript: Gilead Sciences, Inc.
| 1 day | +0.92% | ||
| 1 week | +2.03% | ||
| Current month | +0.11% | ||
| 1 month | +13.03% | ||
| 3 months | +28.42% | ||
| 6 months | +30.11% | ||
| Current year | +39.21% |
| 1 week | 164 |  | 176.58 |
| 1 month | 147.26 | | 176.58 |
| Current year | 116.88 | | 176.58 |
| 1 year | 116.88 | | 176.58 |
| 3 years | 62.07 | | 176.58 |
| 5 years | 57.16 | | 176.58 |
| 10 years | 56.56 | | 176.58 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 28/02/2019 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 31/10/2019 |
Keeley Wettan
CMP | Compliance Officer | - | 17/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 18/08/2016 |
| Director/Board Member | 73 | 31/12/2017 | |
Harish Manwani
BRD | Director/Board Member | 72 | 08/05/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/11/26 | Sell | Chief Executive Officer | -15,000 | 0.0012% | ||
| 15/10/26 | Sell | Executive/Senior Manager | -3,000 | 0.0002% | ||
| 15/10/26 | Sell | Chief Financial Officer | -3,000 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.92% | +2.03% | +44.62% | +125.07% | 212B | |
| +1.44% | +1.63% | +48.17% | +139.63% | 1,276B | |
| -0.47% | +5.49% | +49.03% | +90.68% | 676B | |
| +0.20% | +2.76% | +34.37% | +112.06% | 519B | |
| -0.73% | +0.61% | +37.96% | +66.83% | 388B | |
| -0.48% | +2.34% | +70.66% | +46.02% | 365B | |
| -0.98% | -0.85% | +27.90% | +57.32% | 307B | |
| -0.07% | -1.13% | +2.96% | +35.29% | 287B | |
| 0.00% | +0.86% | +43.74% | +74.04% | 252B | |
| +0.69% | -4.14% | -12.83% | -60.58% | 179B | |
| Average | -0.23% | +2.15% | +34.66% | +68.64% | 446B | |
| Weighted average by Cap. | -0.55% | +2.43% | +40.48% | +90.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 31.36B 28.13B 25.92B 23.54B 44.55B 2,941B 45.8B 310B 124B 1,575B 118B 115B 4,980B | 33.58B 30.11B 27.75B 25.2B 47.7B 3,148B 49.03B 332B 132B 1,687B 126B 123B 5,332B |
| Net income | -5.29B -4.75B -4.37B -3.97B -7.52B -496B -7.73B -52.37B -20.86B -266B -19.86B -19.44B -840B | 10.7B 9.59B 8.84B 8.03B 15.2B 1,003B 15.62B 106B 42.17B 537B 40.14B 39.29B 1,699B |
| Net Debt | 21.05B 18.87B 17.39B 15.8B 29.9B 1,973B 30.73B 208B 82.98B 1,057B 78.99B 77.31B 3,342B | 11.61B 10.41B 9.6B 8.72B 16.5B 1,089B 16.96B 115B 45.78B 583B 43.58B 42.65B 1,844B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/11/26 | US$170.87 | +0.92% | 4,830,594 |
| 09/11/26 | US$169.32 | +1.46% | 4,471,995 |
| 06/11/26 | US$166.89 | -0.41% | 5,817,788 |
| 05/11/26 | US$167.57 | -3.96% | 11,355,969 |
| 04/11/26 | US$174.48 | +4.19% | 9,636,516 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions
